Tiedemann Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-19,500
Closed -$359K 331
2019
Q4
$359K Hold
19,500
0.02% 231
2019
Q3
$344K Hold
19,500
0.02% 247
2019
Q2
$326K Hold
19,500
0.02% 235
2019
Q1
$357K Hold
19,500
0.02% 341
2018
Q4
$387K Hold
19,500
0.02% 324
2018
Q3
$430K Hold
19,500
0.03% 238
2018
Q2
$504K Hold
19,500
0.03% 223
2018
Q1
$311K Buy
19,500
+9,000
+86% +$186K 0.02% 226
2017
Q4
$252K Buy
+10,500
New +$211K 0.02% 200

Other funds holding ASTH

Tiedemann Advisors's ASTH Position: Q1 2020 in Review

Tiedemann Advisors sold out of Astrana Health (ASTH) in Q1 2020, closing a stake of 19,500 shares — an estimated $359K sold.

Tiedemann Advisors first reported a position in ASTH in Q4 2017 and held it in 9 quarters. The position peaked at $504K in Q2 2018. 50 funds tracked by Wall St. Rank hold ASTH as of Q1 2020.

  • Tiedemann Advisors reported no remaining Astrana Health position as of Q1 2020 after selling out during the quarter.
  • Tiedemann Advisors sold 19,500 Astrana Health shares in Q1 2020, an estimated $359K.
  • Tiedemann Advisors first reported a position in Astrana Health in Q4 2017 and held it in 9 quarters.
  • Tiedemann Advisors's Astrana Health position peaked at $504K in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Astrana Health as of Q1 2020.

Based on Tiedemann Advisors's 13F filing for Q1 2020, filed 7 May 2020.